Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.45
+0.08 (0.96%)
At close: May 22, 2026, 4:00 PM EDT
8.38
-0.07 (-0.83%)
After-hours: May 22, 2026, 7:59 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Emergent BioSolutions stock have an average target of $12, which predicts a 42.01% increase from the current stock price of 8.45.
Price Target: $12 (+42.01%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 9, 2026.
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +42.01% | Mar 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +77.51% | Dec 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +77.51% | Sep 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +77.51% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +77.51% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
740.38M
from 742.90M
Decreased by -0.34%
Revenue Next Year
678.72M
from 740.38M
Decreased by -8.33%
EPS This Year
0.96
from 0.93
Increased by 3.17%
EPS Next Year
-0.97
from 0.96
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|
| High | 783.4M | 705.6M | ||||
| Avg | 740.4M | 678.7M | ||||
| Low | 705.6M | 658.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|
| High | 5.5% | -4.7% | ||||
| Avg | -0.3% | -8.3% | ||||
| Low | -5.0% | -11.1% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 1.00 | -1.01 |
| Avg | 0.96 | -0.97 |
| Low | 0.93 | -0.94 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 7.3% | - |
| Avg | 3.2% | - |
| Low | 0.1% | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.